You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine Carcinoma

Showing 1 - 25 of 8,789
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))

Recruiting
  • Gastrointestinal Neuroendocrine Carcinoma
  • Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 1, 2023

Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • (no location specified)
Aug 4, 2023

Surufatinib Plus Sintilimab Combined With Chemotherapy in

Recruiting
  • Gastric Neuroendocrine Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)

Completed
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Athens, Greece
  • +1 more
Sep 16, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

Not yet recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • ZG006
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 6, 2023

Neuroendocrine Carcinoma Trial in Wuhan (Surufatinib and Serplulimab)

Not yet recruiting
  • Neuroendocrine Carcinoma
  • Surufatinib and Serplulimab
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023

Frequency for Patients With Gastric Neuroendocrine Carcinoma

Completed
  • Gastric Neuroendocrine Carcinoma
    • Fuzhou, Fujian, China
      Chang-ming Huang
    Dec 31, 2022

    Epiction of Genomic and Genetic Landscape Identifies CCL5

    Completed
    • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
      • (no location specified)
      Jan 27, 2023

      Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

      Not yet recruiting
      • Neuroendocrine Carcinoma of the Bladder
      • Bladder Cancer
      • (no location specified)
      Oct 14, 2023

      Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

      Not yet recruiting
      • Neuroendocrine Tumors
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Feb 17, 2023

      GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

      Enrolling by invitation
      • GEP-NET
      • +3 more
      • Copenhagen, Denmark
        Rigshospitalet
      Jan 24, 2023

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

      Recruiting
      • Neuroendocrine Tumor Grade 3
      • +2 more
      • Tianjin, Tianjin, China
        Rui Liu
      Nov 17, 2022

      Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

      Not yet recruiting
      • Small Cell Lung Carcinoma (SCLC)
      • Neuroendocrine Neoplasms
      • BI 764532
      • [89Zr]Zr-BI 764532
      • (no location specified)
      Jul 31, 2023

      High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) Trial in San Francisco, Boston, New York (Pembrolizumab, Irinotecan,

      Completed
      Has Results
      • High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
      • San Francisco, California
      • +2 more
      Dec 5, 2022

      Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

      Active, not recruiting
      • Neuroendocrine Tumors
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 24, 2023

      Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

      Active, not recruiting
      • Oncology
      • Neuroendocrine Carcinoma
      • Liposomal Irinotecan
      • +3 more
      • Glasgow, United Kingdom
      • +3 more
      Dec 2, 2022

      Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

      Not yet recruiting
      • Advanced Prostate Cancer
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Sep 25, 2023

      Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

      Enrolling by invitation
      • Breast Cancer
      • +3 more
      • Copenhagen, Denmark
        Rigshospitalet
      Jan 18, 2023

      Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

      Recruiting
      • Small Cell Lung Cancer
      • Neuroendocrine Carcinoma
      • Chiba, Japan
      • +1 more
      Jan 16, 2023

      Merkel Cell Carcinoma, Neuroendocrine Carcinoma of the Skin, Trabecular Carcinoma of the Skin Trial in Tampa (Lenvatinib Oral

      Recruiting
      • Merkel Cell Carcinoma
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      Dec 30, 2022

      Patients With Neuroendocrine Cancer of the Cervix

      Recruiting
      • Cervical Large Cell Neuroendocrine Carcinoma
      • +21 more
      • Follow-Up
      • Medical Chart Review
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

      Not yet recruiting
      • Metastatic Malignant Neoplasm in the Viscera
      • +4 more
      • Lutetium Lu 177 Dotatate
      • (no location specified)
      Jan 25, 2023

      Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

      Not yet recruiting
      • Neuroendocrine Carcinomas
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 22, 2023

      Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

      Not yet recruiting
      • Advanced Malignant Solid Neoplasm
      • +18 more
      • Clinical Encounter
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Jul 24, 2023